(Corrects the name of the EMA head in paragraph 2 of the original story published on December 7)
BRUSSELS (Reuters) – (Corrects the name of the EMA head in paragraph 2 of the original story published on December 7)
The head of the European Medicines Agency (EMA) on Tuesday said that it could soon approve the COVID-19 vaccine developed by U.S. biotech company Novavax.
“The vaccine from Novavax could be authorised in the very near future,” Emer Cooke told EU health ministers during a public session of a meeting in Brussels.
(Reporting by Francesco Guarascio; Editing by David Goodman)
